| Breast Inflammatory Carcinoma studied in …STUDIED_INderived56 of 56show fewer |
|---|
| → studied in | NCT03598257Phase 2 · active not recruiting Radiation Therapy With or Without Olaparib in Treating Patients With Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04030507NA · active not recruiting Screening Magnetic Resonance Imaging of the Brain in Patients With Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02876302Phase 2 · completed Study Of Ruxolitinib (INCB018424) With Preoperative Chemotherapy For Triple Negative Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02411656Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Stage IV Metastatic or Recurrent Inflammatory Breast Cancer or Triple-Negative Breast Cancer Who Have Achieved Clinical Response or Stable Disease to Prior Chemotherapy · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02623972Phase 2 · active not recruiting A Phase 2 Study of Eribulin Followed by AC as Preoperative Therapy for HER2-negative Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03012100Phase 2 · active not recruiting Multi-epitope Folate Receptor Alpha Peptide Vaccine, GM-CSF, and Cyclophosphamide in Treating Patients With Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01730833Phase 2 · completed Pertuzumab, Trastuzumab, and Paclitaxel Albumin-Stabilized Nanoparticle Formulation in Treating Patients With HER2-Positive Advanced Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT07474090NA · recruiting Personalized Exercise Program for Survivors of Breast Cancer, STEPS-BC Trial · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02971748Phase 2 · active not recruiting Pembrolizumab in Treating Patients With Hormone Receptor Positive, Localized Inflammatory Breast Cancer Who Are Receiving Hormone Therapy and Did Not Achieve a Pathological Complete Response to Chemotherapy · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03202316Phase 2 · active not recruiting Atezolizumab, Cobimetinib, and Eribulin in Treating Patients With Chemotherapy Resistant Metastatic Inflammatory Breast Cancer · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03941756NA · recruiting Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00477100recruiting Biospecimen and Medical Data Collection and Tumor Biopsy in Creating Research Tissue Registry in Patients With Inflammatory or Invasive Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02876107Phase 2 · active not recruiting Carboplatin and Paclitaxel With or Without Panitumumab in Treating Patients With Invasive Triple Negative Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01525966Phase 2 · active not recruiting Carboplatin and Paclitaxel Albumin-Stabilized Nanoparticle Formulation Before Surgery in Treating Patients With Locally Advanced or Inflammatory Triple Negative Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03101748Phase 1/Phase 2 · terminated Neratinib and Paclitaxel With or Without Pertuzumab and Trastuzumab Before Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05383196Phase 1/Phase 2 · active not recruiting Onvansertib + Paclitaxel In TNBC · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05415215Phase 3 · completed A Study to Evaluate Patient Preference for Home Administration of Fixed-Dose Combination of Pertuzumab and Trastuzumab for Subcutaneous Administration in Participants With Early or Locally Advanced/Inflammatory HER2-Positive Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04636710NA · recruiting Refining Local-Regional Therapy for IBC · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05795101Phase 2 · recruiting TRUDI: TDXD+Durva in HER2+/Low IBC · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03515798Phase 2 · active not recruiting Study of Immunotherapy in Combination With Chemotherapy in HER2-negative Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05041101Phase 1/Phase 2 · terminated Grapiprant and Eribulin for the Treatment of Metastatic Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01938833Phase 1/Phase 2 · terminated Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT04660929Phase 1 · unknown CAR-macrophages for the Treatment of HER2 Overexpressing Solid Tumors · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05177796Phase 2 · withdrawn Panitumumab and Pembrolizumab in Combination With Neoadjuvant Chemotherapy for the Treatment of Stage III-IV Triple Negative Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03872388Phase 2 · terminated Atorvastatin in Treating Patients With Stage IIb-III Triple Negative Breast Cancer Who Did Not Achieve a Pathologic Complete Response After Receiving Neoadjuvant Chemotherapy · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06057636NA · withdrawn Hypnosis for Pain in Black Women With Advanced Breast Cancer: A Feasibility Study · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT06131632NA · not yet recruiting Conserving Surgery in Inflammatory Breast Cancer After Neoadjuvant Chemotherapy · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02221999Phase 2/Phase 3 · active not recruiting Weekly Paclitaxel and Cisplatin to Treat Hormone Receptor Positive and Triple Negative Breast Cancer Patients · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01417286Phase 2 · completed Accelerated Radiation Therapy After Surgery in Treating Patients With Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02658812Phase 2 · terminated Talimogene Laherparepvec in Treating Patients With Recurrent Breast Cancer That Cannot Be Removed by Surgery · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT05093387Phase 1 · withdrawn SGT-53, Carboplatin, and Pembrolizumab for the Treatment of Metastatic Triple Negative Inflammatory Breast Cancer · condition mapped ONTOLOGY_EXACT · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT03184558Phase 2 · terminated Bemcentinib (BGB324) in Combination With Pembrolizumab in Patients With TNBC · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02227082Phase 1 · completed Olaparib and Radiotherapy in Inoperable Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01755130NA · terminated Laser Optoacoustic and Ultrasonic Imaging System Assembly in Finding Changes in Tumors in Patients With Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02324088Phase 3 · completed Interest of Maintenance Chemotherapy After Induction Treatment for Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02682693Phase 2 · completed Denosumab as an add-on Neoadjuvant Treatment (GeparX) · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01583426Phase 3 · completed Nanoparticle-based Paclitaxel vs Solvent-based Paclitaxel as Part of Neoadjuvant Chemotherapy for Early Breast Cancer (GeparSepto) · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02892734Phase 2 · terminated Ipilimumab and Nivolumab in Treating Patients With Recurrent Stage IV HER2 Negative Inflammatory Breast Cancer · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02879513Phase 3 · unknown Trial of Adjuvant Chemotherapy in Breast Cancer Patients With Pathological Partial Response and Complete Response to Neoadjuvant Chemotherapy · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01894451early Phase 1 · completed Pilot Study of Zirconium-89 Bevacizumab Positron Emission Tomography for Imaging Angiogenesis in Patients With Inflammatory Breast Carcinoma Receiving Preoperative Chemotherapy · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00513695Phase 2 · completed Sunitinib Malate, Paclitaxel, Doxorubicin Hydrochloride, and Cyclophosphamide Before Surgery in Treating Patients With Stage IIB-IIIC Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00986609early Phase 1 · completed MUC1 Vaccine for Triple-negative Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02125344Phase 3 · completed A Phase III Trial Comparing Two Dose-dense, Dose-intensified Approaches (ETC and PM(Cb)) for Neoadjuvant Treatment of Patients With High-risk Early Breast Cancer (GeparOcto) · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00003199Phase 2 · completed Combination Chemotherapy and Peripheral Blood Stem Cell Transplant Followed By Aldesleukin and Sargramostim in Treating Patients With Inflammatory Stage IIIB or Metastatic Stage IV Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00344071completed Pilot Study of Inflammatory Breast Cancer in Egypt and Tunisia · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT02199418Phase 2 · completed Addition of Cisplatin to Neoadjuvant Therapy for T Locally Advanced Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01426880Phase 2/Phase 3 · completed Addition of Carboplatin to Neoadjuvant Therapy for Triple-negative and HER2-positive Early Breast Cancer · condition mapped CURATED_BROADER · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00070252Phase 1/Phase 2 · completed Neoadjuvant Tipifarnib, Docetaxel, and Capecitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors or Stage IIIA or Stage IIIB Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01880385Phase 1 · unknown Efficacy and Safety of Bevacizumab in the Neodjuvant Treatment of Inflammatory Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00049114Phase 2 · completed Tipifarnib, Doxorubicin, and Cyclophosphamide in Treating Women With Locally Advanced Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00004074Phase 1 · completed Interleukin-12 and Trastuzumab in Treating Patients With Cancer That Has High Levels of HER2/Neu · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00016276Phase 3 · terminated Combination Chemotherapy, Surgery, and Radiation Therapy With or Without Dexrazoxane and Trastuzumab in Treating Women With Stage III or Stage IV Breast Cancer · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01641406Phase 2 · unknown "Phase II Study of PET Guided Neoadjuvant Chemotherapy (NAC) and Oncotype Guided Hormonal Therapy of Breast Cancer" · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT01038258NA · unknown Monitoring Response After The First Chemotherapy Cycle After Neoadjuvant Breast Cancer Therapy · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00891280Phase 1 · unknown Dose-escalation Study of Oral CX-4945 · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |
| → studied in | NCT00340158completed Establishing an Inflammatory Breast Cancer Registry · condition mapped ALIAS · 56 trials mapped (18 active) | — | — | Breast Inflammatory Carcinoma | 1 | Observed | clinicaltrials | graph → |